Marriott’s CEO Arne Sorenson diagnosed with pancreatic cancer

Arne Sorenson, the affable president/CEO of global megachain Marriott International, was diagnosed earlier this week with stage 2 pancreatic cancer by doctors at The Johns Hopkins Hospital in Baltimore, Md.

In an internal message, Sorenson told associates, “The cancer was discovered early. It does not appear to have spread and the medical team—and I—are confident that we can realistically aim for a complete cure. In the meantime, I intend to continue working at the company I love. Let me make one request; look ahead with me. We have great work underway at Marriott. I am as excited by what we can accomplish together as I have ever been.”

Sorenson began working with Marriott in 1996, holding positions as senior vice president/business development, executive vice president, chief financial officer and president of continental European lodging before becoming president/chief operating officer in 2009. In 2011 he was elected to the company’s board of directors and in 2012 he became the company’s first CEO without the Marriott family name.

FREE DAILY NEWSLETTER

Like this story? Subscribe to Operations!

Hospitality professionals turn to Operations as their go-to source for breaking news on guest rooms, food & beverage, hospitality trends, management, and more. Sign up today to get news and updates delivered to your inbox daily and read on the go.

Sorenson will begin chemotherapy next week and will remain in his role as he undergoes treatment, according to the company, which added his doctors anticipate doing surgery by year’s end.

Read more on